Sigachi Industries has initiated civil works for its next phase of capacity expansion -- an advanced 12,000 MTPA Microcrystalline Cellulose (MCC) project at its Dahej SEZ unit in Gujarat. This strategic move aligns with Sigachi’s long-term vision of operational resilience, safety-first design, and continued global leadership in the excipient industry.
The Dahej MCC Project reflects Sigachi’s determination to rise stronger, with smarter systems, globally benchmarked safety features, and capacity augmentation focused on uninterrupted supply to its valued global clientele.
Sigachi Industries is an industry leader in the field of Pharma Excipients, Nutra and food ingredients. The company has rapidly established itself as one of the largest manufacturers of Microcrystalline Cellulose worldwide.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: